Skip to content


  • Oral presentation
  • Open Access

Single centre experience of the replacement of ascending aorta with different types of valve-containing conduit

  • 1,
  • 1Email author,
  • 1,
  • 1,
  • 1,
  • 1 and
  • 1
Journal of Cardiothoracic Surgery20138 (Suppl 1) :O9

  • Published:


  • Aortic Valve
  • Mitral Valve
  • Aortic Root
  • Vascular Graft
  • Mechanical Valve


To compare immediate postoperative surgery results in patients after replacement of ascending aorta and aortic valve with various modifications of valve-containing conduit.


Replacement of ascending aorta and aortic valve from 2009 till 2013 was performed in 194 patients (18; 9,3% redo) with pathology of the aortic root. In 19 cases BioValsalva conduit was used (9,3%); in 15 pts (7,7%) allografts and in 6 (3,1%) stentless bioprosthesis were used with “full-root” technique; vascular graft conduits containing stented bioprosthesis in 16 pts (8,2%) or different types of mechanical valve in 139 (71,6%) were used with modification of Bentall procedure. The average age of the patients was 55,7±12,2 years, 158 men (81,4%). 34 patients (17,5%) underwent emergency surgery due to acute dissecting of the thoracic aorta.


Hemiarch operation were performed in 8 cases, aortic arch complete replacement – in 20 cases; concomitant coronary artery bypass (CABG) – in 33 cases (17%); concomitant correction on mitral valve – in 34 cases (35%). In-hospital mortality were 7,8 % (n=15, 95%CI 5,7%–9,1%) and did not depend on the type of the conduit used. Mortality in emergency and in redo was not significantly higher 12,5% vs 6,9% (χ2–1,05, p=0,2).Cross-clamp and CPB time significantly differed for various types conduits (p < 0,05). Frequency of reopen due to postoperative bleeding did not differ between groups averaging 8,2% (n=16, χ2–3,31, p=0,93). In the BioValsalva group a smaller prosthesis diameters (21-23 mm) were used often (χ2–36,79, p=0,012). However effective opening area did not significantly differ for different types of conduits with mean iEOA 1.2±0,18 cm2/m2 (p=0,09).


The results show that BioValsalva prostheses are noninferior to other conduits used if choosing smaller valve diameter. Further observation of these patients is required in order to assess long-term results and determining optimum type of valve-containing conduit.

Authors’ Affiliations

Cardiac Surgery Department, Belarus Cardiology Centre, Minsk, Belarus


© Andraloits et al; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.